Key facts
- It has raised $2.5M.
- Notable investors include Draper Associates, Grid Exponential, MANA Tech, START Global, The Ganesha Lab.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Eywa
- ·The full record, as it builds
Funding rounds
No funding rounds for Eywa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eywa
Operator of a biotech startup intended to develop new technologies to produce psychedelics. The company designs the processes and products to boost the adoption of psychedelic medicine, harnessing the power of biosynthesis to provide patient-centered treatments, enabling patients to get better mental health treatments.
- Sector
- Healthcare
- HQ
- Montevideo, Uruguay
- Founded
- 2022
- Employees
- 7
- Website
- eywa.bio/
- Ownership
- Privately Held (backing)
Eywa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eywa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eywa in its N-PORT filings yet. We sweep new filings monthly.